Application of the recombinant outer membrane protein omp26 vaccine and characterization of the omp26 gene from nontypeable haemophilus influenzae clinical isolates

Liyan Zhang,Zhiyue Lv,Zhenwen Zhou,Zhongdao Wu
DOI: https://doi.org/10.19193/0393-6384_2020_6_528
2020-01-01
Acta medica mediterranea
Abstract:Nontypeable Haemophilus influenzae (NTHi) strains are associated with significant morbidity and mortality and have become more common than typeable Haemophilus influenzae type b (Hib) strains in the vaccine era. There is phenotypic and genetic diversity in different NTHi strains. Outer membrane protein P26 (OMP26) might serve as a genetic marker to identify the diversity and offer a component as a potential vaccine against infections caused by various NTHi strains. In this study, 31 NTHi clinical isolates from infants and children with respiratory illness in south China were identified based on the capsular serotypes using slide agglutination serotyping (SAST) and the bexA gene. The omp26 gene encoded by the 31 NTHi isolates and the three reference strains were characterized by sequence amplification, and the consistency was compared with the target strain 86-028NP genome . Twenty-five genetic and 10 protein subtypes of OMP26 were found in these strains .71vo new gene sequences were discovered in this study. Four omp26 genes from various strains (CG8, CG18, CG40, ATCC 49247) were amplified and cloned into pGEX-4T-1. All purified recombinant OMP26 (rP26) were immunogenic and elicited a high antibody titre in mice. Western blotting confirmed these results. Vaccination with rP26 enhanced bacterial clearance and prevented lung lesions in NTHi-infected BALBIc mice.
What problem does this paper attempt to address?